Zobrazeno 1 - 10
of 182
pro vyhledávání: '"R, Heuschkel"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W. Hyer, I. Davies, Franco Torrente, Richard K Russell, Prithviraj Rao, Nadeem A. Afzal, M. Green, Fevronia Kiparissi, N. Ayub, Michael Murphy, Michelle Wilson, G. T. Ho, Billy Bourke, Astor Rodrigues, Paraic McGrogan, J. Fell, Christine Spray, R. Heuschkel, Anthony K Akobeng, P Rogers, S. Naik, Adrian G. Thomas, G. Mahdi, David C. Wilson, Andrew Fagbemi, S Vaish, S Loganathan, Neil Shah
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:946-953
Aliment Pharmacol Ther 2011; 33: 946–953 Summary Background Adalimumab is efficacious therapy for adults with Crohn’s disease (CD). Aim To summarise the United Kingdom and Republic of Ireland paediatric adalimumab experience. Methods British Soci
Autor:
D C, Wilson, A G, Thomas, N M, Croft, E, Newby, A K, Akobeng, A, Sawczenko, J M E, Fell, M S, Murphy, R M, Beattie, B K, Sandhu, S G, Mitton, D, Casson, M, Elawad, R, Heuschkel, H, Jenkins, T, Johnson, S, Macdonald, S H, Murch
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 50:S14-S34
Objective: to systematically review the evidence base for the medical (pharmaceutical and nutritional) treatment of paediatric inflammatory bowel disease. Methods: key clinical questions were formulated regarding different treatment modalities used i
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Heuschkel, Wallace Crandall, Meena Thayu, Subra Kugathasan, Allan Olson, Anthony R. Otley, Mary B. Leonard, Anne M. Griffiths, Jewel Johanns, Colleen Marano, Gigi Veereman Wauters, Robert N. Baldassano, Jeffrey S. Hyams
Publikováno v:
Clinical Gastroenterology and Hepatology. 6:1378-1384
Crohn's disease (CD) is associated with altered bone metabolism. This study examined changes in bone formation and resorption after infliximab induction and associations between bone biomarkers, linear growth, and disease activity (Pediatric Crohn's
Autor:
Harland S. Winter, R. Heuschkel, Wallace Crandall, G Liu, Gigi Veereman Wauters, James Markowitz, Jewel Johanns, Suzanne Travers, Subra Kugathasan, Stanley N. Cohen, Jeffrey S. Hyams, Robert N. Baldassano, G. D. Ferry, Anne Griffiths, Allan Olson
Publikováno v:
Gastroenterology. 132:863-873
The REACH study evaluated the safety and efficacy of infliximab in children with moderately to severely active Crohn's disease.Patients (n = 112) with a Pediatric Crohn's Disease Activity Index (PCDAI) score30 received infliximab 5 mg/kg at weeks 0,
Autor:
John Fell, S. H. Murch, F Arnaud-Battandier, Nadeem A. Afzal, S Davies, John A. Walker-Smith, M Paintin, R. Heuschkel
Publikováno v:
Digestive Diseases and Sciences. 50:1471-1475
Data supporting a response to treatment with exclusive enteral nutrition in pediatric colonic Crohn's disease are few. We examined clinical and biochemical responses of ileal, colonic, and ileocolonic Crohn's disease and assessed the endoscopic and h
Autor:
R. Heuschkel
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 29:S160-S165
Induction of a remission in children with Crohn's disease is increasingly successful. However this success is dependent on what measure we use to define "remission." Achieving a clinical remission is possible in70% of children with Crohn's disease at
Autor:
S. Koletzko, B. Niggemann, A. Arato, J. A. Dias, R. Heuschkel, S. Husby, M. L. Mearin, A. Papadopoulou, F. M. Ruemmele, M. G. Sch?ppi, Y. Vandenplas, STAIANO, ANNAMARIA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::6dc2fdc1564ca6a6a7b1627eccb24033
http://hdl.handle.net/11588/568104
http://hdl.handle.net/11588/568104
Autor:
S. H. Murch, R. Heuschkel, F Arnaud-Battandier, Nadeem A. Afzal, S Davies, J. Fell, H. J. van der Zaag-Loonen, Bert H. F. Derkx
Publikováno v:
Alimentary Pharmacology & Therapeutics. 20:167-172
Crohn's disease is a chronic debilitating disorder affecting a child's physical and emotional well-being. Recent emphasis on 'quality of life' (QOL) has led to re-evaluation of available medical treatments. To assess prospectively change in QOL, clin